Updated:
Cardinal Partners
Cardinal Partners is a New York City venture capital firm founded in 1995, led by John Hurley, focusing on healthcare and technology investments.
Cardinal Partners
Cardinal Partners was founded in 1995 by John Hurley, a former healthcare investment banker, and operates as a venture capital firm headquartered in New York City. It targets early-stage healthcare and technology companies, managing capital from institutional investors, including endowments and foundations. The firm invests across several sectors, including biotechnology, medical devices, healthcare services, and enterprise software. It typically leads or co-leads Series A rounds, with a focus on companies addressing large unmet medical needs or operational inefficiencies in healthcare. Known portfolio companies include Aegerion Pharmaceuticals and Horizon Discovery, among others (per public record). Cardinal Partners also maintains a presence on the West Coast through a San Francisco office, and its geographic focus is primarily North America. Cardinal Partners does not publicly disclose its total AUM or deployment figures. It operates a single venture strategy without adjacent vehicles such as philanthropy or real estate arms. The firm recently extended its team with a new partner hire in an undisclosed capacity (per industry reports, 2024). What distinguishes Cardinal Partners is its longevity in the healthcare venture space, with a single managing partner who has led the firm for over 25 years, and its deliberate focus on early-stage investments where capital can define the company's trajectory. The firm does not pursue later-stage growth equity or fund-of-funds structures, maintaining a hands-on approach with portfolio companies.
General information
Firm type
Venture Capital
Year founded
1995
AUM
$500M - $1B (Altss estimate)
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Principals
John A. Hurley
Managing Partner
Robert C. Minicucci
Managing Partner
David L. Berman
Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Cardinal Partners?
John Hurley has served as Managing Partner since founding the firm in 1995. He is joined by Managing Partner Robert C. Minicucci and Partner David L. Berman, who lead deal sourcing and portfolio management (per public record).
What investment stages does Cardinal Partners target?
Cardinal Partners focuses on early-stage venture capital, primarily Series A rounds. It typically writes initial checks of $2 million to $10 million per company, and often leads or co-leads the round (per public record).
Which sectors does Cardinal Partners invest in?
The firm invests across healthcare subsectors: biotechnology, medical devices, healthcare services, and digital health. It also selectively makes enterprise software investments with healthcare applications. It does not invest in consumer internet, fintech, or clean energy.
Does Cardinal Partners participate in fund commitments or only direct deals?
Cardinal Partners operates as a venture capital firm making direct investments into portfolio companies. There is no public evidence of it committing capital to external funds as a limited partner; it appears focused solely on direct venture deals.
How does Cardinal Partners source proprietary deal flow?
The firm leverages its 25+ year network of entrepreneurs, academic institutions, and industry executives in healthcare. It does not use a formal scouting program or rely on third-party intermediaries, instead depending on direct relationships built over time (per public record).
What is Cardinal Partners' relationship with its limited partners?
As a traditional venture firm, Cardinal Partners raises capital from institutional LPs, including endowments, foundations, and family offices. It does not disclose its LP base publicly, and the firm's structure is a standard GP-LP partnership with a management company.
Where does the underlying wealth come from for Cardinal Partners?
Cardinal Partners is a venture capital firm, not a family office, so there is no single wealth origin. Its capital is pooled from institutional LPs. The firm itself does not manage personal wealth of a single family or individual.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: